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Abstract 
 
 
In the present study, electrophysiological and behavioral effects of compromised Gama-
Aminobutyric Acid (GABAergic) transmission were investigated in adult Rhesus macaque 
monkeys (N=2).  GABAergic transmission was perturbed in the putamen by administration of a 
GABAA receptor antagonist, gabazine (10 and 500 µM), via a microdialysis-local field potential 
(MD-LFP) probe.  Resultant changes in striatal local field potentials (LFPs) were measured as an 
assay of synchrony.   
Gabazine perfusion evoked discrete large amplitude spikes in LFPs in all subjects, and 
the frequency and shape of individual spikes were concentration-dependent.  Pre-treatment with 
the GABAA receptor agonist, muscimol (100 µM) blocked the gabazine-induced events, 
confirming a role for GABAA receptors in the effects.  Behavioral manifestations of gabazine 
treatment were observed only at the maximum concentration.  Unusual facial movements 
suggested aberrant electrical activity was propagated from striatum to motor cortex, perhaps via 
reentrant circuits.  These results support a role for GABAergic transmission in segregation of 
striatal circuits. 
 
 
INDEX WORDS: local field potentials, microdialysis-local field potential probe, gabazine, 
  synchronized oscillatory discharge, Rhesus macaque
  
 
 
 
The Role of GABAergic Transmission in Mediation of Striatal 
Local Field Potentials (LFPs) 
 
 
by 
 
 
Drew Seiscio 
 
 
 
 
A Thesis Submitted in Partial Fulfillment of the Requirement for the 
Degree of 
Master of Science 
in the College of Arts and Sciences 
Georgia State University 
 
 
 
 
2008 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by  
 
DREW SEISCIO  
 
2008 
 
 
  
 
 
 
The Role of GABAergic Transmission in Mediation of Striatal 
Local Field Potentials (LFPs) 
 
by 
 
Drew Seiscio 
 
 
  Major Professor  Andrew Clancy 
 
 Committee Members:  Kyle Frantz 
   Thomas Wichmann 
     
 
 
Electronic version approved: 
 
Office of Graduate Studies 
College of Arts and Sciences 
Georgia State University 
August 2008
  
 
iv 
 
 
ACKNOWLEDGEMENTS 
 
 
I would like to thank my thesis advisor, Dr. Andrew Clancy, and my 
committee members, Dr. Kyle Frantz and Dr. Thomas Wichmann.  Furthermore, 
this work would have not been possible without the excellent help and support of 
Dr. Olivier Darbin.  I would also like to thank the graduate coordinator LaTesha 
Warren for her guidance and forbearance.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
v 
 
 
Table of Contents 
 
Acknowledgements …………………………………………  iv  
List of Figures ……………………………………………….  vi 
and Tables 
 
List of Abbreviations ……………………………….............. vii 
 
General Introduction ……….………………………................  1 
Circuitry of the Basal Ganglia …….………………………..   1    
Evidence for reentrant circuits ……...………………………  2 
Striatal cellular makeup …………….……………...............  4 
A lateral inhibitory network ………….……………..……... 5 
GABA receptors …………………….……...……………  6 
 Consequences of circuit desegregation …..………................  7 
 Local field potentials …………………….…..…………….  7 
 
Materials and Methods ……………………….……………...  10 
Results ……………………………………….…..……….....  18 
Discussion …………………………………….…………….  29 
Bibliography ………………………………………..............  40 
 
 
 
  
 
vi 
 
List of Figures and Tables 
 
 
Figure 1   Direct and Indirect Pathways …………………….. 3 
 
Figure 2   Schematic Representation of MD-LFP Device ….. 13 
 
Figure 3  Schematic Representation of Study Protocol …… 15 
 
Figure 4 Representative Samples of Synchronized  
Events …………………………………………… 19 
 
Figure 5 Representative Sample of Sustained  
 Synchronized Events ……………………………. 20  
 
Figure 6 Dose Effect of Striatal Gabazine on number  
  of Sustained Synchronized Events ……………… 23 
 
Figure 7 Effect of pre-infusion of Muscimol on number 
  Synchronized Events   …………………………… 24 
 
Figure 8 Time course of Synchronized Events …………… 25 
 
Figure 9 Time Course of the Duration of Synchronized ….. 27 
  Events 
 
Table I  Summary of Dose-Dependence (Gabazine)  
  and LFP Events  …………………………………. 22 
 
Table II Summary of Muscimol’s Effect on  
Gabazine Evoked LFP Events ……………………28 
 
 
 
  
 
vii 
 
List of Abbreviations 
 
AHP =  Afterhyperpolarization 
 
Bg =   Basal Ganglia 
 
DBS =  Deep Brain Stimulation 
 
EEG =  Electroencephalography 
 
Fs =   Fast-Spiking (neurons) 
 
GABA =  Gama-Aminobutyric Acid  
 
GPe =   Globus Pallidus External (segment) 
 
GPi =   Globus Pallidus Internal (segment)  
 
HD =   Huntington’s Disease 
 
LFP =   Local Field Potential 
 
MD-LFP =  Microdialysis-Local field Potential (probe) 
 
MSN =  Medium Spiny Neuron 
 
PD =   Parkinson’s Disease 
 
SEs =   Synchronized Events 
 
SMA =  Supplementary Motor Area 
 
SOD =  Synchronized Oscillatory Discharge 
 
SNc =   Substantia Nigra Pars Compacta 
 
SNr =   Substantia Nigra Pars Reticulata 
 
STN =  Subthalmic Nucleus 
 
TANS =  Tonically Active Neurons 
 
VLm=   Ventralis Lateralis Pars Medialis 
 
VLo =   Ventralis Lateralis Pars Oralis
  
 
1 
 
 
Introduction 
 
Circuitry of the Basal Ganglia 
The Basal Ganglia (Bg) are subcortical structures known for their contributions to motor 
activity and movement disorders, including Parkinson’s and Huntington’s Diseases.  Major 
nuclei of the basal ganglia include input structures such as the striatum (putamen and caudate 
nucleus) and subthalamic nucleus (STN); output structures such as the internal segment of the 
globus pallidus (GPi) and the substantia nigra pars reticulata (SNr); and modulatory structures 
such as the external segment of the globus pallidus (GPe) and the substantia nigra pars compacta 
(SNc).  These nuclei play significant roles not only in motor functions, but also in limbic and 
cognitive functioning (Alexander et al., 1990).  Re-entrant circuits of various modalities connect 
cortex, Bg, and thalamus (Alexander et al., 1990).  Evidence suggests that these circuits are 
segregated, i.e. there is little anatomic overlap between functionally different loops, and little 
correlation between the electrophysiologic activities of neighboring neurons (Gatev et al., 2006; 
Guzman et al., 2003; Bergman and Deuschl, 2002; Plenz and Aertsen, 1996.) The specific aim of 
the present study was to investigate the role of neuronal transmission, primarily via the 
transmitter Gama-Aminobutyric Acid (GABA), in the segregation of these channels. Local field 
potentials, (LFPs) were the primary assay used to investigate the integrity of GABAergic 
transmission, which was manipulated via a GABA-A receptor antagonist and agonist, gabazine 
and muscimol, respectively. 
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The motor circuit is representative of the other pathways, in terms of anatomy and 
physiology (Alexander et al., 1986).  The circuit originates in the arcuate premotor area, motor 
cortex, and somatosensory cortex then projects in succession to the putamen,  
ventrolateral area of the GPi and caudolateral area of the SNr.  Subsequent signals to the 
ventralis lateralis pars oralis (VLo) and the ventralis lateralis pars medialis (VLm) of the 
thalamus are relayed back to relevant cortical areas (Alexander et al., 1986).      
 
Within each circuit there appear to be a so-called ‘direct’ and ‘indirect’ pathways 
traveling through the nuclei of the basal ganglia (Smith et al., 1998; Alexander et al., 1990). The 
direct pathway originates in the striatum and projects to the Bg output nuclei, GPi and SNr.  The 
indirect pathway is more circuitous, involving connections between striatum and GPe, GPe and 
STN, and between STN and GPi/SNr.  The direct and indirect pathways may counterbalance one 
another (Marsden and Obeso, 1994; Figure #1).    
 Evidence for Reentrant Circuits 
These circuits have been mapped both anatomically and electrophysiologically.  Early 
anatomical experiments used antereograde or retrograde tracing techniques, but more recent 
studies have employed herpes simplex I virus to label entire circuits via trans-synaptic retrograde 
transport of labeled viral particles (Middleton and Strick, 2000; Hoover and Strick, 1999; 
Jorritsma-Byham et al., 1994; Cassel, 1993).  For example, trans-synaptic labeling enabled 
Middleton and Strick (2000) to show the precise cortical origins and termination sites of motor 
cortico-basal ganglia-thalamo-cortical loops. 
 Electrophysiological studies with both single-unit and microstimulation approaches have 
also helped to delineate specific circuits and their function. For example  
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Fig 1:   
Direct and Indirect Pathways - The diagram presents an outline of the basic circuitry of 
the Basal Ganglia, in particular emphasizing the direct and indirect pathways.  The direct 
pathway, primarily mediated by the (dopaminergic) D1 receptor, creates an excitatory effect on 
movement, and is characterized by the path of striatum to the output nuclei (GPi/SNr) to 
thalamus to cortex. The more circuitous indirect pathway, primarily mediated by the D2 receptor, 
creates an inhibitory effect on movement, and is characterized by the path of striatum to the GPe 
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to the STN to the output nuclei, finally returning to thalamus and cortex.  (Source: Alexander et 
al., 1990) 
 
Middleton and Strick (2000) combined single-unit recording with viral tract tracing to 
explore visual-motor integration in monkey brain (Middleton and Strick, 2000).  The  
majority of neurons recorded during these experiments (working memory tasks) were in  
the middle third of the pallidum (rostro-caudal dimension).  Subsequent tract tracing from  
that specific region revealed a projection traveling to the SMA, which had been ascribed  
a role in guiding sequential movements that require working memory (Russo et al.,  
2002).  
 
 
Striatal Cellular Makeup 
 
The data reported here result from an investigation of LFPs in the striatum.  The striatum 
is the largest structure in the Bg and is composed essentially of the putamen and caudate nucleus.  
It is the main input structure, receiving significant afferent projections from virtually all parts of 
cortex (Parent et al., 1995; Gerfen, 1992).  Striatal circuitry is comprised of one major type of 
projection neuron, the medium spiny neuron (MSN), and at least four categories of interneurons 
(Kawaguchi et al., 1995).    
The GABAergic MSNs are by far the largest cellular constituents of the striatum, with 
population estimates ranging from 75 to nearly 98 percent of the total number of striatal cells 
(Tepper et al., 2004; Kawaguchi et al., 1995).  MSNs project to two different targets (GPe and 
GPi/SNr) and express various neurotransmitter receptors.  MSNs are quiescent under basal 
conditions (Gatev et al., 2006; Guzman et al., 2003; Plenz and Aertsen, 1996).  Their activity is 
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strongly driven by cortical and thalamic glutamatergic inputs.  These neurons send (inhibitory) 
axon collaterals to neighboring neurons.   
 
The structure and function of certain populations of striatal interneurons have also been 
studied extensively.  One of the major interests of the present study was the mechanism by which 
MSNs are electrophysiologically segregated; it is in this area that GABAergic interneurons are 
thought to play a significant role.  Of the three primary classes of striatal inhibitory interneurons, 
the Fast-Spiking units (Fs) are the best characterized from a variety of parameters (Tepper et al., 
2004).  Structurally, they possess approximately similar dimensions to MSNs, e.g., cell somata 
spanning tens of micrometers.  Their relevant electrophysiologic profile includes the firing of 
brief action potentials and possession of large and rapidly peaking AHPs (Tepper et al., 2004; 
Kawaguchi et al., 1995).  Another notable characteristic sets these GABAergic neurons apart 
from other inhibitory influences in the striatum is their spontaneous activity (Mallet, 2005; 
Bracci, 2003).   
 
Other interneuron populations in the striatum are either lesser known or appear not to be 
relevant to the present study.  Nitric oxide synthetase/somatostatin-containing interneurons and 
calretinin-containing interneurons are both similar to Fs units in that they use GABA as their 
primary neurotransmitter, but neither is described as well in the literature.  Another group of 
interneurons, the cholinergic ‘Tonically Active Neurons’ (or TANs), may play a role in the 
detection of salient stimuli (Graybiel et al., 1995, Kawaguchi et al., 1995).     
 
A Lateral Inhibitory Network 
 A lateral inhibitory network, potentially producing a striatal center–surround mechanism 
(similar to that of the retina), has been postulated to play a role in the segregation of neuronal 
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populations or circuits within the Bg (Alexander et al., 1990; Groves, 1983).  This mechanism 
may operate on a number of levels, including the information paths flowing through the nuclei of 
the Bg and the level of individual nuclei (Alexander et al., 1990).  For example the indirect 
pathway may provide the inhibitory surround, while the direct pathway supplies the disinhibitory 
drive.  
 
The extensive local GABAergic axon collaterals of MSNs may be important sources of 
inhibition in the striatum (Bar-Gad and Bergman, 2001; Parent et al., 1995; Gerfen, 1992; 
Groves, 1983).  The major targets of these collaterals include other MSNs, and populations of 
interneurons, namely the Fs subtype (Mallet, 2005; Tepper et al., 2004; Bolam et al., 2000).  
Although far fewer in number, Fs interneurons may also provide inhibition to this network.  
Terminals from these neurons are anatomically placed to provide highly effective inhibitory 
post-synaptic potentials (IPSPs), and the strength of these IPSPs is stronger than that of MSN’s 
(Tepper et al., 2004; Jaeger et al., 1995).  Regardless of the source of inhibition, be it MSNs, Fs, 
or a combination, one important function of the inhibitory network is to maintain the segregation 
of the reentrant circuits described above (Guzman et al., 2003; Plenz and Aertesen, 1996).  .    
 
GABA Receptors 
 GABA, the primary neurotransmitter that maintains segregation, acts at either ionotropic 
GABAA receptors or, metabotropic GABAB receptors.  GABAA receptors mediate fast inhibitory 
transmission, while GABAB receptors mediate slow inhibitory transmission.  The most relevant 
receptors for our study were GABAA.  Thus to manipulate GABAergic transmission we used the 
competitive and selective GABAA receptor antagonist gabazine (Jones et al., 2001), and the 
selective GABAA receptor agonist, muscimol (Jones et al., 2001, 1998).   
  
 
7 
 
GABAA receptors, or subunits that comprise the receptors, are located throughout the 
basal ganglia, including the STN, both pallidal segments, and the striatum (Charara et al., 2005; 
Galvan et al., 2004; Smith et al., 2000).  Subunits of the GABA-A receptor (α1, β2/3 and 
γ2), have been shown on MSNs and on interneurons (Galvan et al., 2004; Fujiyama et al., 2000), 
often in the core of putative GABAergic synapses (Galvan et al., 2004; Fujiyama et al., 2000).       
 
Consequences of Circuit Desegregation  
 
Segregation of information in specific circuits appears critical to normal behavior (Joel 
and Weiner, 1994).  Damage to this circuitry, either by anatomical lesion or compromise of 
electrical signaling, may result in pathology.  In fact, precise location of an insult or interference 
may predict the type of resultant pathology (Middleton and Strick, 2000).   
  The emergence of synchronized oscillatory discharge (SOD) amongst neuronal 
populations that normally are electrophysiologically segregated may result in a greater 
correlation of firing patterns amongst these cells, resulting in a reduction of relevant signal 
quality (Joel and Weiner, 1994).  This type of phenomenon may play a role in such syndromes as 
Huntington’s Disease (HD) and Dystonia.  Reduced GABAergic transmission within the striatum 
may also be a factor in these disorders (Fredow and Loscher, 1990).  SOD can be studied via 
recording LFPs. 
 
Local Field Potentials   
 
The type of electrical activities that can be recorded with wires introduced into the brain 
depend on the physical dimensions of the electrodes.  Electrodes with a very small tip (on the 
order of a few microns) will be sensitive to focally generated activity, but will not be 
significantly influenced by electrical phenomena generated more than a few hundred 
  
 
8 
 
micrometers away from the electrode tip.  Such ‘micro’-electrodes can therefore be used to 
record the activities of individual neurons or fibers.  The physical dimensions of such electrodes 
determine their electrical characteristics – they tend to have a high impedance, and act 
effectively as a high-pass filter with a high cut-off frequency.  By contrast, electrodes with larger 
tip sizes record potentials generated by a much larger volume of tissue (up to several millimeters 
in size).  The physical characteristics of the electrode-tissue interface results in a low electrode 
impedance, and imparts filter characteristics on these electrodes that relatively favor the 
recording of lower frequencies.  Such electrodes are not sensitive to the activities of individual 
neurons.  Potentials recorded from such ‘macro’-electrodes are called ‘local field potentials’ 
(LFPs) and reflect the net sum of all electrical activities within the vicinity of the electrode.  
LFPs are low-frequency potentials, and are influenced by synaptic potentials, synchronized 
neuronal spiking, and changes in glial membrane potentials (Goldberg et al., 2004, Logothetis, 
2003).    
In light of our concern with segregation of striatal circuitry, perhaps the most essential 
attribute of LFPs is that fluctuations in the local field potential may indicate the degree of 
synchronization between neuronal populations.  Boraud and colleagues state that currents must 
be synchronized in time and space in order to influence the LFP significantly (Boraud et al., 
2005).  LFPs are thought to be ‘population windows’ of sorts on various aspects of neuronal 
behavior, and as such are valuable assays. However, the majority of studies conducted to date 
have been carried out within the cortex, not the Bg.  The relative lack of knowledge on Bg LFPs 
was significant motivation in the development of the present protocol. 
In order to investigate the nature of GABAergic control of LFPs in the striatum of the Bg, 
the present study employed a microdialysis-local field potential (MD-LFP) probe.  This probe 
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enables LFP recording with simultaneous microdialysis sampling.  Combinations of LFP 
recording and pharmacological sampling in the same spatial - temporal frame have not been 
possible before, mainly due to the fact that traditional dialysis sampling involved the use of a 
cannula; when both microelectrodes and cannulae were placed in proximity, an untenable signal 
to noise ratio resulted (Obrenovitch et al., 1994).  This circumstance led to the development of 
microdialysis probes that contained recording electrodes.  Originally, their design included only 
a single, silver chloride wire to record LFPs (Obrenovitch et al., 1994).  This improvement still 
left much to be desired in terms of immunity to electrical noise and ability to show neuronal 
circuit events as truly local phenomena (Darbin et al., 2006; Obrenovitch et al., 1994).  This 
situation changed significantly with the addition of a second recording electrode to the probe, 
and a consequent differential grounding setup.  Signal to noise ratios were much improved, 
enabling localization of LFP activity (Darbin et al., 2006).  The general hypothesis, of the 
present study, that segregation between striatal channels is actively maintained by GABAergic 
mechanisms, along with the timely development of the bipolar MD-LFP probe, led to the 
specific aim of this work:  to investigate the contribution of GABAergic mechanisms to the 
maintenance of segregation of electrical activity in the striatum, as assessed via recording of 
LFPs.   
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Materials and Methods 
 
 
Rationale/Overview 
 
 
 To explore the role of GABAergic inhibition in the maintenance of segregation of 
activity of neighboring striatal MSNs, we recorded changes in striatal LFPs evoked by local 
application of GABAergic drugs via reverse microdialysis. Pharmacological manipulations and 
electrical recordings were made via a combined microdialysis LFP recording, MD-LFP probe.  
 Two monkeys were used.  Surgical procedures were performed to attach a recording 
chamber to the animal’s skull allowing continued access to the brain throughout 
experimentation.  Once the animals recovered from surgery, electrophysiological mapping 
established anatomical boundaries of the striatum.   Resultant maps were used to place the MD-
LFP probe in the target area of the motor striatum, i.e., the putamen.   After accurate probe 
placement and an equilibration period, the microdialysis tubing of the MD-LFP probe was used 
to infuse a GABAergic agonist (muscimol) or an antagonist (gabazine) into the putamen.  
Before, during, and after the drug application, LFPs were recorded.   
 
Specific Research Design 
 
Animals 
 
 Two female Rhesus monkeys (Macaca mulatta) were used in this study, each weighing 
approximately 5 kg.  Animals were housed individually in standard primate cages (Primate 
Products, Miami, Fl), and had ad libitum access to food and water.  Before experimental 
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procedures began, animals were trained to accept contact and handling by the experimenters.  
They were also trained to sit in a primate chair for extended periods.   
 All experimental protocols were performed in accordance with the NIH Guide for the 
Care and Use of Laboratory Animals (Anonymous, 1996), and the PHS Policy on Humane Care 
and Use of Laboratory Animals (amended 2002).  The Animal Care and Use Committee at 
Emory University approved all protocols.  
 
Surgical Procedure 
 In order to place a stainless steel recording chamber (inner diameter 16 mm) on the 
animal’s skull, surgery was conducted under general isoflurane inhalation anesthesia (1-3%) and 
aseptic conditions.  Before setting the chamber, a small circular section of bone was removed 
with a trephine.  The recording chamber allows for chronic access to the brain.  In order to access 
the motor striatum (putamen) the chamber was fixed to the skull stereotactically at an angle of 
50° from vertical in the coronal plane guided by the following anatomical coordinates, (A=12 
mm, L=10 mm, D = 5 mm).  The recording chamber and a head-stabilizing bolt were attached to 
the skull with dental acrylic.   
 
MD-LFP Set-up 
 The MD-LFP probe was constructed of microdialysis tubing and fine electrical wires to 
enable multiple functions (Figure #2).  First a specific length of semi-permeable membrane 
(Hollow Fiber Bundles; molecular weight cutoff: 13,000 Da; Spectra/Por RC; Spectrum 
Laboratories, Inc., Los Angeles, CA), was cut and closed at one end with an epoxy glue.  Then 
the inlet and outlet tubing of the dialysis probe (length 15 cm, i.d. = 40 µm; o.d. = 103 µm; 
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Polymicro Technologies, Phoenix, AZ) were added.  The inlet tube was placed within 100 µm of 
the glue cap, extending 2 mm beyond the end of the outlet tube.  Following placement of the 
tubing, two 20 cm segments of ultra- thin wires (Nichrome/Formvar, bare diameter: 0.0020”, 
coated diameter: 0.0026”, A-M Systems, Inc.), were placed in the probe.  Insulation was 
carefully removed from one end of the wires, and the ends were soldered to a connector (D-Sub 
Crimp Contacts – Jameco, USA).  The probe end of the wires was de-insulated to a length of 100 
µm.  The impedances of the wires were matched to lie within a 100 – 200 KΩ range.  
(Impedance matching improves common mode rejection in the bipolar recording set-up. 
Common mode rejection refers to the ability of the probe to reject signals common to both wires.  
This characteristic improves the signal to noise ratio of the activity that the probe records.)  The 
wires were then added to the probe next to the tubing, in such a way as to ensure the wire tips are 
2.5 mm from each other. 
 The entire probe was then inserted into a sleeve of tubing (polyimide) so that a 3 mm 
segment of both wire tips and inlet/outlet tubing extended out of the sleeve.  Ten-millimeter 
sections of stainless steel tubing (Small Parts, Miami Lakes, FL) were glued to the proximal ends 
of the inlet/outlet tubing of the probe for connections to a microliter pump.  The wires and tubing 
(stainless steel and polyimide) were then secured in a small plastic holder, which added 
structural support (CMA, Solna, Sweden).   
 The system was perfused with aCSF (composition in mM: 147.0 Na+, 4.0 K+, 1.0 Mg2+, 
1.2 Ca2+ and 153.2 Cl-; CMA, Slona, Sweden), delivered at a rate of 2 µl/min from gas-tight 
syringes, which were driven by a microliter syringe pump (CMA120; CMA, Solna, Sweden).  
The pump simultaneously drove two syringes, which were connected to the inlet tubing of the  
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Figure 2: 
  A schematic representation of the MD-LFP device indicating the following: 
(a) inlet tube, (b) outlet tube, (c) semi-permeable membrane, (d) polyimide tubing, 
(e) first wire-electrode, (f) second wire-electrode, (g) glue plug, (h) glue in 
polyimide tubing ‘sleeve’. Source: Darbin, O et al., 2006  
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probe via a liquid switch (CMA110; CMA, Solna, Sweden), which allowed switching between 
infusion solutions without the introduction of air bubbles.   
 
Sampling Routine 
 
 Before the MD-LFP probe was used it was flushed overnight to ensure that the system 
was properly primed.  Thirty minutes before the start of the experiment the system was perfused 
with a solution of artificial cerebrospinal fluid (aCSF) composed of a composition similar to that 
described in the previous section. After this perfusion period the probe was placed in the brain 
via a microdrive and delivered to a relevant target based on mapping data.  Once the probe was 
located correctly, extracellular fluid was allowed to stabilize for a period of sixty minutes (Figure 
#3).  Following stabilization, baseline striatal LFPs were recorded for twenty minutes as a 
control set of data for all experimental groups. There were five experimental groups or series of 
injections in this study.  They were organized by the following parameters.  Group 1 was a 
control group, in which LFPs were recorded at baseline without drug injection. Three 
experimental groups  (#’s 2, 3 and 4) were recorded in the presence of gabazine (0.1, 10 or 500 
µM respectively), introduced to the medium perfusing the microdialysis system starting 40 
minutes after the beginning of the recording, i.e., T = 0, and lasting for a period of 20 minutes.  
The last experimental group (#5), consisted of perfusion with muscimol alone (100 µM) at T = 
20 minutes, for a 20 minute period, immediately followed by a 20 minute perfusion with a 
solution containing both muscimol (100 µM) and gabazine (10 µM).  In all groups, except group 
#1, LFP recording continued for 120 minutes after switching back to regular aCSF.     
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Figure 3: 
 
Schematic representation of the protocol used in this study. First, the MD-LFP probe was 
perfused overnight using distilled water. Then, the device was inserted into the brain area of 
interest and a one hour equilibration period was implemented to allow the tissue to recover from 
the penetration. After this period, the recording session was started and this defined the T0 of the 
experiment. Control group (group 1) was recorded for 3 hours without drug injection. Three 
groups (2,3,4) were treated by infusion of gabazine (0.1, 10 or 500 µM respectively) 40 min after 
the beginning of the recording for a period of 20 min. The last group (5) was treated at 20 
minutes with muscimol (100 µM) alone for 20 min followed by a 20 min period of perfusion 
with a mixed solution of muscimol (100 µM) and gabazine (10 µM). 
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Electrophysiological Recording 
 
Two types of electrophysiological signals were recorded:  single-unit spiking activity was 
used to delineate the boundaries of the striatum, and LFPs were used to ascertain the degree of 
synchronous activity amongst neuronal populations within the striatum.  The striatum was 
mapped using microelectrodes (FHC, Bowdoinham, ME) with an impedance value range of 0.5 – 
1 MΩ and standard single-unit recording methods.  A microdrive (MO-95B, Narishige, Tokyo, 
Japan) was used to lower the single microelectrode through the various regions of the brain en-
route to the putamen.  To avoid damage to the microelectrode tip, we used a guide tube to insert 
the electrodes past the dura mater.  The spiking activity was amplified (DAM-80 amplifier, WPI, 
Sarasota, Fl), filtered 400 – 10,000 Hz, Krohn-Hite, Brockton, MA), and visualized with a digital 
oscilloscope (DL 1540, Yokogawa, Tokyo, Japan).  The signals were also made audible with an 
audio amplifier.  LFP signals were recorded with an EEG amplifier (Model 8-16 Amplifier, 
Grass) and low-pass filtered at a range of 0.5 - 75 Hz.  LFP recording wires were interfaced with 
the EEG amplifier via an impedance adaptor (Model HZP High Impedance Probe, Grass, West 
Warwick, RI).   
 
Histology  
 
 At the end of these experiments the animals received an overdose of pentobarbital 
(100mg/kg) and were then perfused transcardially with cold oxygenated Ringer solution, 
followed by a mixture of 4% paraformaldehyde and 0.1% glutaraldehyde in phosphate buffer 
(0.1 M, pH 7.4).  The brain was blocked, frozen, and sectioned in the parasagittal plane in 50 µm 
sections.  Sections were stained via cresyl violet.  Recording sites were reconstructed based on 
gliosis patterns and prior electrophysiological mapping data.   
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Data Analysis 
 
 We observed that gabazine induced rhythmically recurring spike-waves in the striatal 
LFP record.  To generate numerical descriptors of the frequency and duration of  
these events, we analyzed the data with custom-designed algorithms in Matlab (Mathworks, 
Natick MA).  First the numerical signal was re-sampled to 241 Hz and  
filtered in the band 0.5-35 Hz.  The new signal was then segmented in adjacent 10-second 
windows.  Each individual window was visually analyzed in order to exclude windows  
with artifacts, to identify the beginning and ending of individual gabazine-induced synchronized 
events, and to calculate the duration of the gabazine-induced changes (if any).  The number of 
spike-wave events (Figure #8) and their duration (Figure #9) were estimated over 5 minute 
periods.  These data are displayed in the median and 25th – 75th percentile format, via and inter-
group comparisons were carried out with non-parametric tests as the data did not follow a normal 
distribution (Glantz, 1997).   
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Results 
 
Effects of Gabazine Infusion 
 
GABAergic inhibition was blocked with various concentrations of the GABAA-receptor 
antagonist gabazine.  LFPs recorded from the MD-LFP system were monitored during drug 
exposure.  Gabazine exposure resulted in the emergence of recurring large-amplitude LFP 
fluctuation.  Experiments with various concentrations of gabazine demonstrated a dose-
dependent relationship, such that increasing concentrations of gabazine correlated with an 
increasing frequency and amplitude of the spike-wave events (Figure #4).  A dose-dependent 
relationship was also observed with regard to complexity in shape of the evoked events.  From 
here on these phenomena will be termed synchronized events (SEs).  When local areas of the 
putamen were perfused with concentrations of 10 or 500 µM of antagonist, individual SEs 
demonstrated a dose-dependent relationship not only regarding amplitude and frequency, but 
also in terms of complexity of waveform shape (Figures #4 & #5).  At both concentration values, 
SEs increased in amplitude to an extent approaching 3 orders of magnitude.  Regarding 
complexity of shape, at the 10 µM concentration SEs had the shape of a spindle or spike. In 
contrast, at the 500 µM value, SEs were more complex, (Figure #4b and Figure #5), and were 
characterized by several spikes during a shift in the baseline potential.  One possible reason for 
increased complexity maybe wider spread of antagonist at higher concentration, and a 
consequential increase in the number of receptors/cells affected or entrained at small, but slightly 
varying time frames.    
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A 
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Figure 4: 
Representative samples of synchronized events (SEs) with spike or spike/wave shapes 
recorded in the striatum of the awake monkey after local application of GABAA antagonist 
gabazine using MD-LFP device. (A) Traces recorded after infusion of gabazine at 10 µM. The 
lower part represents a magnified view of one particular SE (*); (B) Traces recorded after 
infusion gabazine at 500 µM. The lower part represents a magnified view of one particular SE 
(*). Increase in gabazine concentration results in an increase in number of spikes and in 
complexity of their shapes. 
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Figure 5: 
 Representative sample of sustained synchronized events (SSEs) recorded in the striatum of an 
awake monkey after local application of the GABAA antagonist gabazine at a concentration of 
500 µM using reverse microdialysis.  Portions of the figure labeled B-D refer to the sections in 
subplot A marked with an asterisk. 
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In addition to more complex patterns, we also observed more sustained periods of 
synchronization on both the individual SE level (labeled SSE in Figure #5 and Table I), and in 
terms of synchronized behavior enduring on a population level (Figures #5, #8, & #9) during 
infusion of the higher concentration of gabazine (500 µM).  On the individual SE level, 
paroxysmal activity began immediately after an SE began, and consisted of several seconds of 
high frequency activity at lower amplitude than the preceding SE (Figure #5).   
 The number of SEs increased overall in a dose-dependent manner (Figure #6).  No SEs 
were seen in the control protocols of the experiments; nor were SEs detected during the 
injections of 0.1 µM concentration of gabazine.  However, at the 10 µM and 500 µM 
concentrations of antagonist a significant dose-dependent relationship in SE increase was 
observed.  Specifically, the number of SEs observed during the recording sessions increased 
193.5% from 10 µM to 500 µM (Figure #6). The timing by which SEs occurred was affected 
both on a global and individual scale by the concentration of drug perfused.  At the 10 µM 
dosage the number of SEs that occurred within 5-minute increments increased to a peak level of 
60 SEs ten minutes after gabazine administration commenced.  This maximum was followed by 
a gradual decline during the rest of the experiment (Figure #7).  At a concentration of 500 µM, 
the maximum value of SEs that occurred per 5-minute increment continued to increase 
approximately 60 minutes after the start of the antagonist perfusion to a value of 110 SEs.  This 
frequency did not decline over the remainder of the experiment.  
 SE duration also increased on an individual waveform level, depending on the gabazine 
concentration in the perfusion medium (Figure #8).  With 10 µM gabazine, individual SEs 
increased in duration less than 10 minutes after commencement of gabazine infusion and 
culminated in a maximum value of 700 ms at approximately t = 70 minutes.  Once attained, this  
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Table I:  Dose-dependence of gabazine effects.   
  
The data are presented in termsof the number of experiments in which SEs, SSEs 
 or behavioral changes were seen.  
Condition 
Incidence  
of SEs 
Incidence  
of SSEs 
Incidence 
for partial 
seizure 
Control 0/4 0/4 0/4 
Gabazine 0.1 µM 0/6 0/6 0/6 
Gabazine 10 µM 7/7 0/7 0/7 
Gabazine  500 µM 5/5 4/5 2/5 
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Figure 6: 
Dose effect of striatal gabazine administration on number of SEs evoked locally.   
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Figure 7:  
Time course of SEs occurrence evoked locally by striatal gabazine infusion. (○) after 
infusion of gabazine 10 µM; (●) after infusion of gabazine 500 µM.  Data are median and 25th-
75th percentiles (*: p<0.05). 
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Figure 8:  
 
Time course of the duration of SEs evoked locally by striatal gabazine infusion. (○) after 
infusion of gabazine 10 µM; (●) after infusion of gabazine 500 µM.  Data are median and 25th-
75th percentiles (*: p<0.05). 
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maximal value began to decline soon after and continued for the remainder of the experiment.  
With 500 µM gabazine, individual SE durations increased at a faster rate, and reached a maximal 
value between 700 – 800 ms and maintained this plateau for the remainder of the experiment.  
The greatest duration of individual SEs was not significantly different between lowest and 
highest concentrations of antagonist, however a plateau was only maintained in the case of the 
500 µM value.   
Behavioral manifestations were observed only when the highest concentration of 
antagonist was used.  The behavior occurred in two sessions of gabazine infusion, and included 
subtle facial movements characterized by eye blinking, chewing, and grinding of the teeth.  In 
one experiment, excessive salivation was also observed.  These behavioral manifestations were 
never observed during infusions with the lower concentration values of antagonist, i.e., 0.1 and 
10 µM.  See Table I for a summary of experiments involving various concentrations of gabazine 
only.   
 
Experiments with Co-administration of Muscimol and Gabazine:   
 
These experiments examined interactions between muscimol and gabazine in the 
modulation of LFP events.  Muscimol was perfused starting 20 minutes before gabazine 100 µM, 
and continued for the duration of the gabazine exposure.  Under these conditions, effects of 
gabazine on striatal LFP quality and quantity were blocked  
(Figure #9 and Table II).
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Figure 9:  
Effect of pre-infusion of muscimol (100 µM) on SEs number elicited  
by striatal infusion of GABAA antagonist gabazine (10 µM). 
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Table II:  Effect of muscimol on gabazine evoked LFP events  
Pre- and co-treatment Conditions 
Incidence 
for SE 
None Gabazine 10 µM 7/7 
Muscimol 100 µM Gabazine 10µM 0/6 
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Discussion 
 
 
The present data set reveals a gradient of effects that correlates with levels of inhibition 
in a striatal/putamen locus.  Up to a specific plateau, the higher the concentration of gabazine, 
the larger in magnitude and more complex in nature the effects observed on the LFP.  A role for 
GABAA receptors in these gabazine effects is supported by pretreatment with muscimol, which 
blocked gabazine effects.  Overall, these data support a role for GABA in the maintenance of 
segregation of striatal circuitry, as well as the idea that the integrity of information within striatal 
channels is ensured in part via lateral inhibitory transmission (Wichmann & DeLong, 2003; 
Gerfen, 1992).  
Specifically, we observed that the frequency of SEs increased in a dose-dependent 
manner during gabazine infusion, and that SEs were significantly larger in amplitude than the 
background LFP waveforms.  Other parameters that were at least in part concentration-
dependent included the time-course of events and the complexity of the shape of evoked SEs.  
Certain “uneventful” periods were also significant.  For example, the lack of SEs in the LFP 
background during perfusions of the lowest concentration of gabazine is noteworthy.  Finally, 
behavioral manifestations were observed only in the few conditions using the highest 
concentration of antagonist.   
Generally, the data support the hypothesis that strong inhibitory transmission is necessary 
to prevent the emergence of abnormal oscillations in the LFP.  GABAA receptors are widely 
distributed in the striatum, located on both MSNs and Fs units (Smith et al., 2001); and therefore, 
antagonism of the GABAA receptor should interfere with most GABAergic transmission (in 
addition to communication mediated by the GABAB receptor).  Not surprisingly then, our results 
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are consistent with the view that in the alert, resting macaque, GABAergic inhibition is normally 
present and largely mediated by GABAA receptors.   
Upon diffusion of drug an adequate distance into striatal tissue - consequently binding a 
sufficient number of GABAA receptors - a requisite number of striatal cells and synapses 
terminating on them were disinhibited, allowing for the emergence of the large amplitude LFP 
events.  As alluded to in the introduction, currents must be synchronized in time and space in 
order to significantly influence the LFP (Boraud et al., 2005; Buzsaki, 2004).  In theory then, 
SEs in the LFP reflect a sufficient level of synchronization occurring amongst synapse or neuron 
populations.   
The lack of synchronized events at the lowest concentration of gabazine is noteworthy.  
This result suggests that there exists a continuum of disinhibition; at low concentrations SEs 
were not evoked (Faingold et al., 1998; Meldrum & Wilkins, 1984) whereas at higher 
concentrations SEs became more complex in shape and occurred more frequently.  Above this 
threshold the complexity in shape and the frequency of occurrence of SEs were concentration 
dependent.  The primary limiting factors on the antagonist’s effect were most likely its 
extracellular concentration and its distance perfused from the probe (Hoistad et al., 2002). 
Essentially then, changes in SE frequency of occurrence and complexity of shape were a 
function of both of these parameters, although there may have been other more subtle undetected 
factors.  The shape of LFP events and their concentration dependent complexity are attributable 
to the varying quantity of electrically excitable elements contributing to the LFP and to the 
changing qualitative nature of their contributions.  
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Co-administration of Gabazine and Muscimol    
 
 Gabazine failed to induce LFP events in the presence of muscimol.  The rationale 
behind the co-administration experiments was to increase confidence in gabazine’s locus of 
action and to establish that the perturbations seen in the LFP were primarily due to antagonism of 
the GABAA receptor.  Given muscimol’s less selective nature than gabazine (Jones et al., 2001), 
muscimol may block a diversity of -A- receptor subunit combinations, including those that 
gabazine exhibits greatest affinity toward.  Our results support gabazine’s profile in the literature 
as potent competitive inhibitor of the GABAA receptor (Lindquist et al., 2005).   
Although not likely, an ‘order-effect’ could have influenced the present results.   Namely, 
if a set of experiments had been carried out in which gabazine was applied first, the subsequent 
administration of muscimol may or may not have inhibited all evoked SEs.  Muscimol is 
described as a potent agonist (Frolund et al., 2002) with consequent intrinsic ability to out-
compete the natural agonist.  Furthermore, according to Jones and colleagues (Jones et al., 2001 
and 1998) muscimol, and agonists like it, may create an ‘induced-fit’ rearrangement of their 
receptor’s subunits that requires a significant energy outlay for this new configuration to occur. 
Conversely, antagonists such as gabazine create less involved interactions with their relevant 
receptors and, consequently, their action is less expensive from an energetic standpoint.  This 
rationale suggests that perfusion of muscimol secondarily to gabazine would have induced 
limited reversal of the effects evoked herein by the antagonist, primarily because the cost of 
energetic outlay is favorable toward the mechanism of gabazine.  Our findings, while not proving 
a specific locus of action, do support the assertion that antagonism of the GABAA receptor 
generated the emergence of synchronized events.   
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Results in Light of Physiological Concerns  
 
 As mentioned in the introduction, a lateral inhibitory network has been suggested to exist 
within the striatum (Groves, 1983).  The emergence of SEs in our experiments indicates that at 
least partial, if not significant breakdown of the local inhibitory network occurred.  However, 
cortical motor programs were in all likelihood not disrupted (with certain possible exceptions, 
see below), as the animals by and large were resting during the protocols.  The development of 
SEs, does indicate that significant synchronization developed in the local vicinity of the probe, 
primarily caused by the disturbance of GABAergic transmission.    
The potential substrate of this network as described in the introduction, is most likely 
MSNs, Fs interneurons or some combination of these populations.  Do these cell populations also 
contribute to the phenomena observed in the LFP record?  MSNs comprise the overwhelming 
majority of striatal cells (Tepper et al., 2004), thus by sheer number alone they almost certainly 
contributed to the LFP.  Furthermore, since the LFP is a function of a variety of electrical 
activity, MSN oscillations in membrane potential may have contributed significantly to the 
events observed in the LFP record.  MSN are known to oscillate from a so-called down state 
(least likely to fire) to an up-state (a membrane potential only a few millivolts away from spiking 
threshold) (Wilson and Kawaguchi, 1996).  Since currents must be synchronized in order to 
significantly affect the LFP (Boraud et al., 2005), our data may reflect the synchronous 
oscillations of many MSNs from hyperpolarized states to near threshold.  However, MSNs were 
almost certainly not the only contributors to the LFP.  Fs interneurons possess certain 
characteristics that distinguish them from other striatal populations and make them ideal LFP 
contributors.  These characteristics include an ability to fire spontaneously, significant 
glutamatergic cortical input, and considerable connections to other Fs cells via gap-junctions 
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(Mallet et al., 2005; Tepper et al., 2004; Moore & Grace, 2002).  Electrotonic coupling via gap-
junctions may have played a role in synchronizing the output of Fs cells.   
 
Behavioral Issues 
  
 During two experiments with the highest concentration of gabazine, the animals 
manifested behavioral changes.  Although few in number, the fact that oral/facial movements did 
arise suggests a few interesting possibilities.  One, as described above, significant breakdown of 
an inhibitory network probably occurred allowing for the emergence of synchronized events.  
This synchrony was almost certainly propagated to relevant areas of cortex and most likely by 
electrical means, not by diffusion of drug (Hoistad, 2002).  The direction of propagation from the 
striatum could have been either antero- or retrograde.  The substrate involved in the retrograde 
case would be the circuitry that connects cortex with striatum; if anterograde in nature, the direct 
pathway described in the introduction would be the relevant path (Figure #1).   
 
LFPs Revisited  
Regarding more global issues and questions related to the LFP, since this potential is 
known to propagate over significant distances, on the order of millimeters (Goldberg et al., 
2004), it seems fair to ask, ‘do the SEs in the field potential propagate further in the LFP than the 
actual spread of the antagonist?’  If the LFP is more than just a manifestation of varied electrical 
activity within the neuropil, if it is actually a signal capable of causing effects (Bullock, 1997), is 
there any indication of this in the raw data?   
In effect, what has been partly carried out in this protocol is to shut down a substantial 
proportion of the brain’s inhibitory mechanism, within a small locus.  The resultant lack of 
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balance as manifested by the large amplitude oscillations in the LFP, should in theory, evoke 
some sort of homeostatic response from the brain.  Since proper brain functioning requires a 
balance of excitation and inhibition (Moulder et al., 2006), one could expect to see evidence of 
increased GABAergic transmission – metabolic, electrical, and histological – in areas outside of 
the sphere of influence of the antagonist.  For example increases in GABAergic vesicular 
trafficking and likelihood of release might be detectable (Moulder et al., 2006).   
The question arises then, is there any evidence in the LFP of a homeostatic response 
occurring?  In other words, are there any subtle manifestations in the LFP reflecting the brain’s 
attempt to compensate for the disturbance in GABAergic transmission?  The most fruitful place 
to look for this answer maybe in sections of the LFP record that take place near the end of the 
obvious effect of the antagonist.  The rationale for looking in this area of the record simply being 
that the peak effect of the antagonist may mask any other more subtle compensatory activity.  
Future experiments could also look to sample, via microdialysis, other relevant brain areas 
outside of the area that is influenced by the MD-LFP probe.   
Regarding other subtle aspects of the LFP record, it was evident that at the median 
concentration of antagonist (10 µM) SE’s evoked were simpler in shape than those emerging at 
the higher concentration.  Interestingly, only the SE’s of more complex shape were associated 
with behavioral changes.  Obviously, change in shape of the LFP is not the salient cause of the 
behavior manifestations observed, however, the biological substrate that underlies these changes 
may be of interest.  Are the majority of dose-dependent effects seen in this protocol due solely to 
greater concentrations of antagonist in the local environment and/or greater distance of diffusion 
of the antagonist from the probe? Or are there other factors that operate here as well? Although 
beyond the scope of this work, additional factors possibly include the increased influence of 
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glutamatergic and dopaminergic transmissions subsequent to the elimination of GABAergic 
activity.   
Further interesting questions regarding the LFP record include: ‘why does the sustained 
and complex paroxysmal behavior illustrated in figure #5 develop?”  Is this, too, primarily a 
function of extracellular drug concentration and perfusion distance from the probe?  
Unfortunately, the nature and implications of these ‘seizure-like’ events remain a mystery.  
Finally, the maximum duration of individual SE’s did not change significantly between the 
median and 500 µM concentrations.  Why?  Given the significant difference in concentration 
between the median and highest value, does this result represent some type of plateau that cannot 
be surpassed without an orders of magnitude increase in concentration of drug and a resultant 
greater perfusion distance?   
 
Relevance to Human Pathology 
 
 Major insights into the behavior of individual neurons have been gained from 
electrophysiological experiments.  Most progress has been achieved by single-unit recording.  
Single-unit recording offers valuable insights into neuronal behavior, especially regarding the 
firing rate of units.  Firing rates, however, do not give a comprehensive picture of relevant 
neuronal behavior; emergent oscillation patterns in population activity are also germane.  As 
such, researchers have begun to look at the patterns of the electrical activities of single neurons, 
or populations of cells, as well as LFP fluctuations (Kuhn et al., 2005).  They have found that 
certain frequency bands of synchronized, oscillatory activity can be deemed either antikinetic or 
prokinetic (Brown, 2003).  For example, Williams and colleagues found 11 – 30 Hz synchronous 
oscillations in the LFP between STN and GPi, and these nuclei and cortex, in Parkinsonian (PD) 
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patients undergoing Deep Brain Stimulation (DBS) (Williams et al., 2002).  Furthermore, Brown 
broadly defines the frequency bands below 40 Hz as essentially antikinetic.   
 Our results show fluctuations in the LFP that have maximal frequency values of less than 
1 Hz at both the median and greatest concentration of the antagonist. These frequency values 
would probably not be classified as antikinetic (or prokinetic), and so the question remains 
whether there are any correlations between our results and non–contrived pathological realities, 
i.e., movement disorders.  Some evidence is reported for impaired GABAergic transmission in 
the progression of various diseases.  Two primary examples are Huntington’s Disease and some 
forms of Dystonia.  Fredow and Loscher (1990) observed that the symptoms of a dystonic strain 
of hamsters could be ameliorated or worsened if given drugs that enhanced or impaired 
GABAergic transmission respectively (Fredow and Loscher, 1990).  While Crossman and 
colleagues found that by impairing GABAergic transmission from the medial putamen to the 
lateral globus pallidus (via bicuculline) a chorea type symptomology emerged in monkeys.  They 
reasoned that since there is an impairment in GABAergic signaling from the striatum to the 
globus pallidus in humans suffering from Huntington’s Disease (HD) that compromised 
GABAergic transmission may play at least some part in HD (Crossman et al., 1988). 
Variability in Results and Possible Confounds 
 
 Two female Rhesus monkeys were tested in this protocol.  Due in part to the low number 
of subjects, significant variability was encountered.  Relevant inter-animal differences may 
include differences in the animal’s metabolism, differences in brain architecture and dimensions, 
and differences in cellular population censuses, e.g., neuronal versus glial ratios.  Regarding 
inter-penetration differences, the primary source of variation was differences in location of the 
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MD-LFP probe within the putamen from one injection to another.  Other sources include 
experimenter error regarding timing of perfusions and concentrations values of the 
pharmacological agents.  Furthermore, there was some inevitable variation in the construction of 
one MD-LFP probe and another.  One unavoidable limitation of this protocol, namely the fact 
that only two animals were used, was due to ethical and, in part, economic issues associated with 
nonhuman primate research.  For these reasons multiple observations were carried out in each of 
these animals, rather than other animal model protocols, e.g., rodent paradigms, in which single 
observations are carried out in multiple animals.   
The number of spikes evoked at various antagonist concentrations showed significant 
variability especially at the concentration value of 10 µM.  In general there appeared to be more 
variability at the median concentration value throughout all of the various parameters, e.g., total 
spikes evoked, spike number per 5 minutes and individual spike number.  If this interpretation is 
true, the reason may have to do with a failure to reach a minimum level of 
disinhibition/excitation (alluded to above) at all, or consistently at the 10 µM value.  In the 
experiments conducted regarding spike number per 5 minutes, there appears to be significant 
variation in the data at both concentrations values, although the greatest periods of difference 
manifest at different time periods in the overall experiments, namely, late in the experiment for 
the maximal concentration value, and early to middle periods for the median value.  Reasons 
why may include variance in the length of activity of the antagonist at the 500 µM concentration 
and, as above, lack of threshold levels of excitation/disinhibition achieved at the median value.  
In the data collected regarding individual spike durations, the greatest variability appeared to 
occur again at the median concentration value and also, in the middle period of the experiment.  
This occurrence may also be attributed to lack of sufficient antagonism of the GABAA receptor.   
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Summary and Conclusions 
 
 The data reported here indicate that perfusion of the GABAA antagonist gabazine at 10 
and 500 µM concentrations by reverse microdialysis evokes discrete, large – amplitude spikes in 
the LFP, which we have termed synchronized events (SEs).  These results suggest that the rate of 
occurrence and the complexity of shape of individual events are dependent on the concentration 
of gabazine.  Behavioral manifestations were seen in only two series of injections using the 
maximal concentration of antagonist.  Pre-administration with the GABAA receptor muscimol 
prevented the development of all coarse and subtle manifestations of the gabazine induced LFP 
events.   
  The data supported our hypothesis that in order for pathological oscillatory behavior 
amongst neuronal populations not to emerge, strong inhibitory transmission is necessary.  Upon 
sufficient breakdown of GABAergic transmission, synchrony may develop. Thus the hypothesis 
that GABAergic mechanisms play a significant role in maintaining the segregation of striatal 
circuitry is supported by our results.  In other words, strong, lateral inhibition within striatum 
may play a role in prevention of unwanted movements from occurring.   
 Possible directions to proceed experimentally with the MD-LFP probe include the use of 
glutamatergic or dopaminergic antagonists and complementary single unit recording in the same 
locus as the probe.  One particularly promising location would be the output nuclei of the Bg.  
Here the production, and potential propagation, of SEs to cortex could be further investigated.  
Recording of cortical EEG to more effectively validate the emergence and spread of 
synchronized oscillatory activity would strengthen the significance of any potential results.   
This work may be relevant to the study of human pathologies in part associated with 
impaired GABAergic transmission.  Consequent imbalance in excitation and inhibition resulting 
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from pathological GABAA receptor signaling may be conducive to the emergence of certain 
motor disorders.  Huntington’s Disease and some forms of Dystonia may be pertinent examples. 
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